Integrated Drug Discovery (IDD)

At Abhinavayan, we are scientists first, driven to accelerate innovation through tailored Integrated Drug Discovery (IDD) solutions. From discovery to clinics, we partner across the R&D spectrum with deep scientific insight and strategic precision. Wherever you are in your journey, we’re here to turn promising science into breakthrough therapies, together.

Click Here

Abhinavayan Biotech:
Your Partner in Transformative Science

Proven Depth in Drug Discovery

Tap into Abhinavayan Biotech’s extensive foundation in Medicinal Chemistry, Biologics Development, Molecular Biology, DMPK, and Translational Research. Our science-driven teams possess decades of combined experience, equipping us to solve the most complex challenges across every stage of drug discovery.

Science That Delivers Results

We convert fundamental research into clinically actionable solutions. Our integrated approaches accelerate the journey from concept to patient, ensuring robust scientific and therapeutic outcomes.

Flexible, Science-First Collaboration

We customize engagement models to fit unique program needs, ranging from flexible FTE arrangements and staged milestones to forward-thinking risk-sharing and consultancy partnerships. Abhinavayan Biotech’s collaboration platforms deliver scientific excellence with transparency and agility.

Accelerating Your Innovations

From initial target validation to IND filing, we empower your project with speed and efficiency. Our scientists guide you through every phase, optimizing timelines and resources to move your breakthroughs forward—faster and smarter.

DALL·E 2025-05-17 15.15.50 - Aesthetic and minimalistic biotechnology-themed wide backgrou

Integrated Drug Discovery

Your strategic partner from Concept to Clinic

Abhinavayan delivers fully integrated drug discovery solutions, expertly guiding programs from initial concept through to clinical readiness.

We support the discovery and development of small molecules, advanced modalities, and biologics, ensuring scientific continuity and operational efficiency every step of the way.

With Abhinavayan, you gain the advantage of a dedicated, seasoned team committed to collaboration and transparency. We work alongside your scientists as an extension of your internal team, offering strategic guidance, helping set clear objectives, executing your customized research plan, and empowering you to make informed decisions at every critical stage.

Consortium
Seamless, cost-effective, and expert-driven journey from concept to clinic

A unique consortium delivering integrated drug discovery and development services. By combining deep expertise across discovery (Abhinavayan), preclinical research (CRO), manufacturing (CDMO), and regulatory domains (Clinical CRO), the alliance empowers pharma and biotech clients to accelerate innovation, optimize resources, and realize faster go-to-market for breakthrough therapeutics.

The consortium unites world-class R&D, seasoned drug development leadership, and robust manufacturing infrastructure.

We reduce complexity, accelerate timelines, and deliver decision-ready data that moves programs forward with clarity and confidence.

Consortium

We support you for the Entire project life cycle

FTE based-Integrated Drug Discovery (IDD) or FFS-based R&D Service (through partners)

Discovery Sciences (Target ID/validation, hit-to-lead and candidate nomination)
IND-Enabling Services (Tox, ADME, regulatory docs)
Regulatory Submissions (India and Global)
Clinical Strategy & Execution (protocols, biomarkers, site support

Integrated Drug Discovery Project Life Cycle

Milestone-driven achievements with multifunctional teams

Strategic Planning

Decisive leadership

Innovation

Back to Services

Contact Our Experts

Dr. Madhavi Mulay

Founder I Director

Email:

contact@abhinavayan.com

nagaraj.gowda@abhinavayan.com

Abhinavayan’s Integrated Drug Discovery (IDD) programs are driven by scientific and regulatory context, not just execution. We combine deep target biology, smart study design, and early regulatory thinking to build de-risked programs and decision-ready data that can move confidently toward the clinic.